Famotidine
Top View
- In Vivo Pharmacodynamic Interaction Between Pipecuronium and Certain H2 Blockers
- Medications to Stop Taking Before Allergy Testing
- Prescription Medications and Hair Loss Or Thinning
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Prescribing Information
- FEP 5 Tier Rx Drug Formulary (607) Standard Option
- Ranitidine, Famotidine, Andplacebo on Intragastric Acidity 83
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- View by the Editor-In-Chief of This Journal
- Potentially Harmful Drugs in the Elderly: Beers List and More
- (12) United States Patent (Io) Patent No.: US 9,526,824 B2 Ferrari Et Al
- Low Dose Famotidine and Cimetidine in Single Postprandial Doses
- Ocular Disorders in Users of H2 Antagonists and of Omeprazole
- |||||I||||IIII US00536466A United States Patent 19 11 Patent Number: 5,364,616 Singer Et Al
- Consultation: Cimetidine, Famotidine, Nizatidine and Ranitidine
- (CD-P-PH/PHO) Report Classification/Justifica
- Medication Alternatives for the Elderly 5/30/08 the Following Table Details the Drugs to Avoid and the Recommended Agents to Be Considered As Alternatives.*
- PEPCID® (Famotidine) Tablets, for Oral Use Tablets: 20 Mg, 40 Mg (3) Initial U.S